1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 3:Previous literature regarding recurrences and retreatment of aneurysms after initial coil embolization
Author Pts/Ayms with Angiographic F/U (%) Mean Angiographic F/U (months) Recurrences (%) Retreated Aneurysms (%) Rebleeding (p.a.) (%) Set of Retreated Recurrences (%) Combined M/M Recoiling (%) Byrne 199928 250/317 pts (78.9) 6–12 38/259 (14.7) 13/250 (5.2) 0.6–2.4 13/38 (34.2) Not reported Cognard 199936 169/203 ayms (83.3) 3.4 26/169 (15.5) 8/169 (4.7) 0.0 8/26 (30.8) Not reported Thornton 200237 141/196 ayms (71.9) 16.7 25/141 (17.7) Not reported 0.5 Not reported Not reported Murayama 20036 489/916 ayms (53.4) 11 102/489 (20.9) Not reported 0.5–1.6 Not reported Not reported Raymond 200314 381/501 ayms (76.5) Not specified* 128/381 (33.6) 39/381 (10.2) 0.3 39/128 (30.5) Not reported Slob 200429 400/488 ayms (82) 6 Not reported 48/400 (12) 1.1 Not reported 0 Henkes 200616 1680/2759 ayms (60.9) Not specified† Not reported 350/1680 (20.8) Not reported Not reported 3 Gallas 20052 571/705 ayms (81) 36 85/571 (14.9) 33/571 (5.8) 0.06 33/85 (38.8) Not reported CARAT 20069 299 pts with clinical F/U Not reported Not reported 35/299 (11.7) 0.11 Not reported 11 Kang 200615 250/522 ayms (47.9) 8 91/250 (36.4) 32/250 (12.8) 0.79 39/91 (42.8) 0 Own data 342/627 ayms (54.5) 28.6 72/342 (21.1) 33/342 (9.6) 0.6 33/72 (45.8) 0
Note:—Pts indicates patients; ayms, aneurysms; F/U, follow-up; p.a., per annum; MM, morbidity and mortality.
* Early F/U (3–12 months) in 353/501 aneurysms and late F/U (>12 months) in 277/501 aneurysms.
† Standard recommendation was to have F/U angiography at 6–12 months. Mean interval between first treatment and first F/U examination was 21 months (median, 14 months).